Advertisement

Neuropraxis

, Volume 5, Issue 5, pp 92–96 | Cite as

Cognitieve stoornissen na chemotherapie

  • S. Schagen
  • F. van Dam
Artikelen
  • 112 Downloads

Samenvatting

Kwaadaardige ziekten kenmerken zich door ongeremde celgroei, infiltratieve groei en metastasering. Behandelingen als chirurgie en radiotherapie zijn in principe lokale behandelingen en kunnen een tumor met zijn infiltratiegroei in omgevende weefsels verwijderen. Deze behandelingen zijn echter niet in staat om uitzaaiingen buiten het operatie- of bestralingsgebied te bestrijden.

Literatuur

  1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, e.a. The European Organization for Research and Treatment of Cancer qlq-c30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 Mar 3;85(5):365–76.Google Scholar
  2. Ahles TA, Tope DM, Frustenberg C, Hann D, Mills L. Psychological and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol 1996; 14:1457–62.Google Scholar
  3. Andrykowski MA, Schmitt FA, Gregg ME, Brady MJ, Lamb DG, Hensley-Downey PJ. Neuropsychological impairment in adult bone marrow transplant candidates. Cancer 1992; 70:2288–97.Google Scholar
  4. Baars J.W. Cytostatica klinisch toegepast. Pharm Weekbl 1997;132:1506–17.Google Scholar
  5. Boogerd W. Neurological complications of chemotherapy. In: Vinken & Bruyn. Handbook of clinical neurology: Intoxications of the nervous system. Part II. Elsevier Science, 1995:527–46.Google Scholar
  6. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Clin Oncol 2000 Jul;18(14):2695–701.Google Scholar
  7. Cull A, Gregor A, Hopwood P, Macbeth F, Karnicka-Mlodkowska H, Thacher N, Burt P, Stout R, Stepniewska K, Stewart M. Neurological and cognitive impairment on long-term survivors of small cell lung cancer. Eur J Cancer 1994; 30a:1067–74.Google Scholar
  8. Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do patients mean when they complain of concentration and memory problems? Br J Cancer 1996; 74: 1674–79.Google Scholar
  9. Devlen J, Maguire P, Phillips P, Crowther D. Psychological problems associated with diagnosis and treatment of lymphomas II: prospective study. Br Med J 1987; 295: 955–57.Google Scholar
  10. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994;30A(1):37–40.Google Scholar
  11. Meyers CA, Abbruzzese JL: Cognitive functioning in cancer patients: Effect of previous treatment. Neurology 1992; 42:434–36.Google Scholar
  12. Meyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D. Evaluation of the neurobehavioral functioning of patients before, during and after bone marrow transplantation. J Clin Oncol 1994; 12: 820–26.Google Scholar
  13. Meyers CA, Byrne K, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 1995; 12: 231–35.Google Scholar
  14. Oosterhout AGM, Ganzevles PGJ, Wilmink JT, de Geus BWJ, Vonderen RGMW, Twijnstra A. Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1996; 5:1037–44.Google Scholar
  15. Oxam TE, Silberfarb PM. Serial cognitive testing in cancer patients receiving chemotherapy. Am J Psychiatry 1980; 137:1263–65.Google Scholar
  16. Parth P, Dunlap WP, Kennedy RS, Lane NE, Ordy JM. Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy. Percept Mot Skills 1989; 68:1227–41.Google Scholar
  17. Rodenhuis S. & Beijnen J.H. Principes van medicamenteuze therapie. In: Veenhof & Voute. Behandeling van Kanker. Bohn Stafleu van Loghum, 2000:27–44.Google Scholar
  18. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999 Feb 1;85(3):640–50.Google Scholar
  19. Sherwin BB. Estrogen and cognitive functioning in women. Proc Soc Exp Biol Med 1998;217(1):17–22.Google Scholar
  20. Silberfarb PM, Philibert D, Levine PM. Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiatry 1980; 137:597–601.Google Scholar
  21. Van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998 Feb 4;90(3):210–8.Google Scholar
  22. Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 1995; 4:61–66.Google Scholar
  23. Wolff S.N., Herzig R.H., Fay J.W., LeMaistre C.F., Brown R.A., Frei-lahr D., e.a. High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. Semin Oncol. 1990 ;17(1 Suppl 3):2–6.Google Scholar

Copyright information

© Bohn Stafleu van Loghum 2001

Authors and Affiliations

  • S. Schagen
    • 1
  • F. van Dam
  1. 1.

Personalised recommendations